Frontier Scientific Solutions announced the appointment of Michelle D’Angelo as Chief Commercial Officer (CCO). D’Angelo brings over 25 years of experience in the pharmaceutical and biotechnology CDMO sector, with deep expertise in commercial leadership, business development, and customer engagement.
D’Angelo has built her career working closely with global life sciences organizations to address complex development and supply chain challenges. She has led commercial initiatives that enhance customer experience while driving sustained business growth, combining strategic vision with a hands-on approach to execution.
“Michelle brings a powerful combination of commercial acumen and deep industry experience,” said Steve Uebele, CEO of Frontier Scientific Solutions. “Her track record translating customer insight into impactful growth strategies will be instrumental as we continue to scale our platform and strengthen our partnerships across the life sciences sector.”
In her role as Chief Commercial Officer, D’Angelo will lead Frontier’s global commercial strategy, including sales and marketing functions, ensuring alignment with evolving client needs and market dynamics. She will play a key role in advancing Frontier’s mission to deliver integrated, end-to-end logistics solutions purpose-built for the life sciences industry and the organizations that support it.
“Frontier is addressing one of the most critical challenges in the life sciences industry, ensuring the safe, compliant, and efficient movement of temperature-sensitive therapies,” said D’Angelo. “I am excited to join the team at this important stage of growth and to help expand our commercial capabilities in support of our clients’ evolving needs.”